diaziquone has been researched along with Uterine Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, B; Blessing, JA; Look, K; Slayton, RE | 1 |
| Blessing, JA; Clarke-Pearson, D; Slayton, RE | 1 |
| Blessing, JA; DiSaia, PJ; Phillips, G; Slayton, RE | 1 |
3 trial(s) available for diaziquone and Uterine Neoplasms
| Article | Year |
|---|---|
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Benzoquinones; Drug Evaluation; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1991 |
A phase II trial of diaziquone (AZQ) in mixed mesodermal sarcomas of the uterus. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Benzoquinones; Drug Evaluation; Female; Humans; Middle Aged; Sarcoma; Uterine Neoplasms | 1991 |
A phase II clinical trial of diaziquone in the treatment of patients with recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
Topics: Aged; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Uterine Neoplasms | 1988 |